Evidence map›Paper›PMID 31281855›Full record

ArticleOpen forum infectious diseases2019

Hepatitis B Virus Prevalence and Vaccination in Men Who Have Sex With Men in West Africa (CohMSM ANRS 12324-Expertise France).

Ter Tiero Elias Dah, Clotilde Couderc, Alou Coulibaly, Malan Jean-Baptiste Kouamé, Mawuényégan Kouamivi Agboyibor, Issa Traoré, Gwenaëlle Maradan, Daniela Rojas Castro, Ephrem Mensah, Camille Anoma and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02626286 (Prevention of HIV Infection in Men Who Have Sex With Men in Sub-Saharan Africa), which is not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02626286 nacompletednot on this map

Prevention of HIV Infection in Men Who Have Sex With Men in Sub-Saharan Africa: Feasibility and Interest of a Quarterly Preventive Global Care (CohMSM)

TypeinterventionalSponsorANRS, Emerging Infectious DiseasesRan2015 to 2021Enrolled885ConditionsHIV InfectionArmsHIV quarterly global care
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 4 countries.

Ter Tiero Elias DahAssociation African Solidarité, Ouagadougou, Burkina Faso.ORCID 0000-0001-9249-579X
Clotilde CoudercIRD, Inserm, Univ Montpellier, TransVIHMI, Montpellier, France.
Alou CoulibalyARCAD-SIDA, Bamako, Mali.
Malan Jean-Baptiste KouaméEspace Confiance, Abidjan, Côte d'Ivoire.
Mawuényégan Kouamivi AgboyiborEspoir Vie Togo, Lomé, Togo.
Issa TraoréAssociation African Solidarité, Ouagadougou, Burkina Faso.
Gwenaëlle MaradanInserm, IRD, Univ Aix-Marseille, SESSTIM, Marseille, France.
Daniela Rojas CastroCoalition Plus, Pantin, France.
Ephrem MensahEspoir Vie Togo, Lomé, Togo.
Camille AnomaEspace Confiance, Abidjan, Côte d'Ivoire.
Bintou Dembélé KeitaARCAD-SIDA, Bamako, Mali.
Bruno SpireInserm, IRD, Univ Aix-Marseille, SESSTIM, Marseille, France.
Christian LaurentIRD, Inserm, Univ Montpellier, TransVIHMI, Montpellier, France.
CohMSM Study Group
Inserm · FRAssociation de Recherche de Communication et d’Accompagnement à Domicile de personnes Vivant avec le VIH · MLEspoir Vie-Togo · TG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough men who have sex with men (MSM) are at high risk of hepatitis B virus (HBV) infection, they do not have access to vaccination in West Africa, which is a highly endemic region. We investigated HBV prevalence and associated factors, as well as acceptability and difficulties of vaccination in MSM enrolled in an operational research program in Burkina Faso, Côte d'Ivoire, Mali, and Togo.

methodsWe followed up 779 MSM in 2015-2018. Participants who were negative for both hepatitis B surface antigen (HBsAg) and antibodies (anti-HBs) at enrollment were offered HBV vaccination. Factors associated with HBV infection were identified using logistic regression models.

resultsOverall, HBV prevalence was 11.2% (95% confidence interval [CI], 9.0%-13.6%). It was lower in Togo than in Côte d'Ivoire (2.7% vs 17.3%; adjusted odds ratio [aOR], 0.12; 95% CI, 0.02-0.28) and higher in participants with 6+ recent male sexual partners (21.0% vs 9.3%; aOR, 1.48; 95% CI, 1.12-1.97). Of 528 participants eligible for vaccination, 484 (91.7%) were willing to be vaccinated and received at least 1 dose (ranging from 68.2% in Abidjan to 96.4% in Bamako;

conclusionsMSM in West Africa should be targeted more for HBV screening and vaccination. Although vaccination is well accepted by MSM, greater training of health care workers and education of MSM are required.

Indexed as

Africahepatitis Bmen who have sex with menprevalencevaccination

Identifiers

PMID31281855
PMCPMC6602381
OpenAlexW2946705507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.